Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹109 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹109 Cr
Mar2024₹-357 Cr
Mar2023₹2,621 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹109 Cr
Positive
Mar2024 ₹-357 Cr
Negative
Mar2023 ₹2,621 Cr
106.48
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,130.0 Cr 7.7% 15.1% 60.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 2.4% 7.1% 14.6% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr -0.2% 3.8% 15.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.8% 10.9% 48.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1% 4% 16.6% Stock Analytics
CIPLA ₹107,427.0 Cr 0.3% -0.9% -6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

7.7%

15.1%

60.7%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses